ErbB2 ELISA Kit
Erythroblastosis Virus ELISA Kit
HER-2 ELISA Kit
HER2 ELISA Kit
c-Neu ELISA Kit

Format: 96-well plate

Form: 96 Tests

Species Reactivity: human

Specificity: Human

Assay Range: 0-3 ng/ml

Assay Time: 4 h

Sample Type: Cell lysates, biological fluids

Positive Control: c-erbB2/c-neu

Kit Contents: Pre-Coated 96-Well Plate, c-ErbB2/c-Neu Lyophilized Standard, Cell Resuspension Buffer, Antigen Extraction Agent, Sample Diluent, Biotinylated Detector Antibody, Detector Diluent, Streptavidin Peroxidase Conjugate, Conjugate Diluent, Wash Buffer, Substrate, Stop Solution, Adhesive Plate Sealers, and a user protocol.

Comments: Detects both c-ErbB2/c-Neu p185 and the extracellular domain p105 cleavage fragment. Positive cell lines: A549, HT29, SK-BR-3, and SKOV-3, or breast, prostate, colon, or ovarian cancer.

Ref.: Hung, M.-C. and Y-K Lau, 1999. Seminars in Oncology 26(Suppl 12), 51. Ouyang, X., et al. 1999. Lancet 353, 1591. Ross, J.S. and J.A. Fletcher, 1999. Am. J. Clin. Pathol. 112, S53. Ross, J.S. and J.A. Fletcher, 1998. Stem Cells 16, 413. Disis, M.L., et al. 1997. J. Clin. Oncol. 15, 3363. Ross, J.S., et al. 1997. Human Pathology 28, 827. Ross, J.S., et al. 1997. Cancer 79, 2162. Xia, W., et al. 1997. Clin. Cancer Res. 3, 3. Cirisano, F.D. and B.Y. Karlan, 1996. J. Soc. Gynecol. Invest. 3, 99. Menden, H., et al. 1994. Cancer Res. Clin. Oncol. 120, 378. Kynast, B., et al. 1993. J. Cancer Res. Clin. Oncol. 119, 249. Gusterson, B. and R. Gelber, 1992. J. Clin. Oncol. 10, 1049. Hetzel, D.J., et al. 1992. Gynecol. Oncol. 47, 179. Hou, L., et al. 1992. Cancer Lett. 65, 215. Leitzel, K., et al. 1992. J. Clin. Oncol. 10, 1436. Carney, W.P., et al. 1991. J. Tumor Marker Oncol. 6, p. 53. Clark, G.M. and W.L. McGuire, 1991. Cancer Res. 51, 944. Langton, B.C., et al. 1991. Cancer Res. 51, 2593. Paterson, M.C., et al. 1991. Cancer Res. 51, 556. Zabrecky, J.R., et al .1991. J. Biol. Chem. 266, 1716. Berchuck, A., et al. 1990. Cancer Res. 50, 4087. Borg, A., et. al. 1990. Cancer Res. 50, 4332. Inglehart, J.D., et al. 1990. Cancer Res. 50, 6701. Kern, J.A., et al. 1990. Cancer Res. 50, 5189. Mori, S., et al. 1990. Jpn. J. Cancer Res. 81, 489. Paik, S., et al. 1990. J. Clin. Oncol. 8, 103. Maguire, H.C. and M.I. Greene, 1989. Seminars in Oncology 16, 148. Ro, J., et al. 1989. Cancer Res. 49, 6941. Slamon, D.J., et al. 1989. Science 244, 707. Tandon, A.K., et al. 1989. J. Clin. Oncol. 7, 1120. Wright, C., et al. 1989. Cancer Res. 49, 2087. Yoshida, K., et al. 1989. Virchows Arch. B Cell Pathol. Mol. Pathol. 57, 285. Fontaine, J., et al. 1988. Oncology 45, 360. Kraus, M.H., et al., 1987. EMBO J. 6, 605. Slamon, D., et al. 1987. Science 235, 177. King, C.R., et al. 1985. Science 229, 974. Shin, C., et al. 1981. Nature 290, 261. Henry, R.J., et al. 1974. Clinical Chemistry, Harper and Row, New York.

R: 23/24/25-35-36/37/38-40-41-43; S: 23-26-36/37/39-45